Hypertriglyceridemia in a COVID-19 Patient: A Case Report | Zendy

Alfateh Noor | Zendy; Zohdi Farea | Zendy; Shakya Majumder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypertriglyceridemia in a COVID-19 Patient: A Case Report

Author(s) -

Alfateh Noor,

Zohdi Farea,

Shakya Majumder

Publication year - 2022

Publication title -

international journal of health sciences and research

Language(s) - English

Resource type - Journals

ISSN - 2249-9571

DOI - 10.52403/ijhsr.20220437

Subject(s) - plasmapheresis , medicine , hypertriglyceridemia , covid-19 , triglyceride , disease , intensive care medicine , pediatrics , infectious disease (medical specialty) , virology , immunology , cholesterol , outbreak , antibody

Most laboratory findings of coronavirus disease (COVID-19) are not specific nor are they reliable in assessing response to treatments. This case report outlines a rare finding of severe hypertriglyceridemia in a COVID-19 patient and, more interestingly, it sheds light on a correlation between clinical improvement and a decrease in hypertriglyceridemia after plasmapheresis treatment. Using a normal triglyceride level as a target for our plasmapheresis treatment resulted in dramatic improvement in our patient’s condition. The patient was treated successfully and discharged from the hospital after nine days.Key words: SARS-CoV-2, COVID-19, Hypertriglyceremia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research